We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current KTTAW market cap is 254.21k. The company's latest EPS is USD -0.7660 and P/E is -8.62.
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
Total Revenue | 241k | 0 | 0 | 0 | 0 |
Operating Income | -5.08M | -3.21M | -3.83M | -3.79M | -5.15M |
Net Income | -5.12M | -3.54M | -3.76M | -3.61M | -5.05M |
Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 0 | 15k | 487k | 0 |
Operating Income | -41k | -4.51M | -14.82M | -15.98M |
Net Income | -41k | -2.17M | -13.94M | -15.96M |
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
Total Assets | 45.18M | 42.05M | 38.15M | 30.66M | 26.12M |
Total Liabilities | 2.68M | 2.91M | 2.56M | 2.28M | 2.72M |
Total Equity | 42.5M | 39.14M | 35.59M | 28.37M | 23.4M |
Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 248k | 53.32M | 45.18M | 26.12M |
Total Liabilities | 7k | 1.9M | 2.68M | 2.72M |
Total Equity | 241k | 51.42M | 42.5M | 23.4M |
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
Operating | -14.56M | -3.39M | -6.87M | -10.11M | -13.43M |
Investing | -2.06M | -50k | 295k | 344k | 398k |
Financing | -3.21M | 264k | 133k | -3.73M | -3.73M |
Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -38k | -3.17M | -14.56M | -13.43M |
Investing | N/A | -22k | -2.06M | 398k |
Financing | 282k | 55.93M | -3.21M | -3.73M |
Market Cap | 254.21k |
Price to Earnings Ratio | -8.62 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 8.42 |
Price to Book Ratio | 5.88 |
Dividend Yield | - |
Shares Outstanding | 20.84M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 0 |
52 Week Change | - |
52 Week High | - |
52 Week Low | - |
Spread (Intraday) | 0.02 (60%) |
Company Name | Pasithea Therapeutics Corporation |
Address |
8 the green ste a dover, delaware 19901 |
Website | https://www.pasithea.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions